Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
38.12%
↑ 158% vs avg
Percentile
P93
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-66.04%
Historical baseline
PeriodValue
202538.12%
2024-24.69%
2023-26.50%
2022-22.12%
2021-19.58%
2020-140.92%
2019-155.85%
2018-5.32%
2017-18.06%
2016-285.51%